France Diabetes Market Report: 2024-2032
The France diabetes market size reached US$ 1,100.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,782.3 Million by 2032, exhibiting a growth rate (CAGR) of 5.33% during 2024-2032.
IMARC’s new report “France Diabetes Market Report: 2024-2032” provides an analytical and statistical insight into the France diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in France. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the France diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the France diabetes market in any form.
What we have achieved in this report:
Comprehensive situation analysis of the France diabetes epidemiology and its dynamics:
Focus of the Analysis:
Historical, current and future prevalence of diabetes in France
Historical, current and future prevalence of type-1 and type-2 diabetes in France
Historical, current and future prevalence of diabetes in the urban and rural regions in France
Historical, current and future prevalence of diabetes among males and females in France
Historical, current and future prevalence of diabetes among various age groups in France
Historical, current and future diagnosis rates for diabetes in France
Historical, current and future drug treatment rates for diabetes in France
Comprehensive situation analysis of the France Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
Performance of the Oral Antidiabetics market in France
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the France Insulin market and its dynamics:
Focus of the Analysis:
Performance of the Insulin market in France
Performance of key classes
Performance of key players
Market outlook
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
- 5 Diabetes Disease Overview
- 5.1 What is Diabetes?
- 5.2 Diabetes Diagnosis and Treatment
- 5.2.1 Diagnosis
- 5.2.2 Treatment
- 5.3 Diabetes Complications
- 6 France Diabetes Epidemiology
- 6.1 Diabetes Population and Prevalence Rates
- 6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
- 6.3 Population and Prevalence Rates by Region
- 6.4 Population and Prevalence Rates by Gender
- 6.5 Population and Prevalence Rates by Age Group
- 7 France Diabetes Market
- 7.1 Market Overview
- 7.2 Market Performance
- 7.3 Impact of COVID-19
- 7.4 Market Forecast
- 7.5 SWOT Analysis
- 7.5.1 Overview
- 7.5.2 Strengths
- 7.5.3 Weaknesses
- 7.5.5 Opportunities
- 7.5.6 Threats
- 7.6 Value Chain Analysis
- 7.7 Porter’s Five Forces Analysis
- 7.7.1 Overview
- 7.7.2 Bargaining Power of Buyers
- 7.7.3 Bargaining Power of Suppliers
- 7.7.4 Degree of Competition
- 7.7.5 Threat of New Entrants
- 7.7.6 Threat of Substitutes
- 7.8 Market Breakup by Segment
- 7.8.1 France Oral Antidiabetics Market
- 7.8.1.1 Historical Market Trends
- 7.8.1.2 Market Breakup by Class
- 7.8.1.3 Market Shares of Key Players
- 7.8.1.4 Market Forecast
- 7.8.2 France Insulin Market
- 7.8.2.1 Historical Market Trends
- 7.8.2.2 Market Breakup by Class
- 7.8.2.3 Market Shares of Key Players
- 7.8.2.4 Market Forecast
- 8 Competitive Landscape
- 8.1 Competitive Structure
- 8.2 Profiles of Key Players
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook